ROCKWELL MEDICAL, INC.
RMTIRockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
Drugs in Pipeline
6
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Aug 13, 2026
16dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
SFP
End Stage Renal Disease
Soluble Ferric Pyrophosphate (SFP)
Renal Failure Chronic Requiring Hemodialysis
Soluble Ferric Pyrophosphate in liquid bicarbonate
End Stage Renal Disease
Heparin
End Stage Renal Disease
Soluble Ferric Pyrophosphate
Kidney Failure
Triferic
End Stage Renal Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
SFP | Phase 3 | End Stage Renal Disease | - | - |
Soluble Ferric Pyrophosphate (SFP) | Phase 3 | Renal Failure Chronic Requiring Hemodialysis | - | - |
Soluble Ferric Pyrophosphate in liquid bicarbonate | Phase 2 | End Stage Renal Disease | - | - |
Heparin | Phase 2 | End Stage Renal Disease | - | - |
Soluble Ferric Pyrophosphate | Phase 2 | Kidney Failure | - | - |
Triferic | Phase 2 | End Stage Renal Disease | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in ROCKWELL MEDICAL, INC.'s drug pipeline?→
CatalystAlert tracks 6 drug candidates in ROCKWELL MEDICAL, INC.'s (RMTI) pipeline across Phase 3, Phase 2. Its lead program is SFP (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is ROCKWELL MEDICAL, INC.'s next FDA catalyst?→
ROCKWELL MEDICAL, INC.'s (RMTI) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track RMTI biotech catalysts?→
Add RMTI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ROCKWELL MEDICAL, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.